Intrinsic value of Hill-Rom Holdings - HRC

Previous Close

$94.71

  Intrinsic Value

$50.70

stock screener

  Rating & Target

sell

-46%

Previous close

$94.71

 
Intrinsic value

$50.70

 
Up/down potential

-46%

 
Rating

sell

We calculate the intrinsic value of HRC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 6.3

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  3.30
  3.47
  3.62
  3.76
  3.88
  4.00
  4.10
  4.19
  4.27
  4.34
  4.41
  4.47
  4.52
  4.57
  4.61
  4.65
  4.68
  4.72
  4.74
  4.77
  4.79
  4.81
  4.83
  4.85
  4.86
  4.88
  4.89
  4.90
  4.91
  4.92
Revenue, $m
  2,835
  2,933
  3,039
  3,153
  3,276
  3,407
  3,546
  3,695
  3,853
  4,020
  4,197
  4,385
  4,583
  4,792
  5,013
  5,246
  5,492
  5,751
  6,024
  6,311
  6,614
  6,932
  7,267
  7,619
  7,990
  8,380
  8,790
  9,220
  9,673
  10,149
Variable operating expenses, $m
  1,447
  1,488
  1,531
  1,578
  1,628
  1,681
  1,738
  1,799
  1,863
  1,931
  1,713
  1,790
  1,871
  1,956
  2,046
  2,141
  2,242
  2,347
  2,459
  2,576
  2,699
  2,829
  2,966
  3,110
  3,261
  3,420
  3,588
  3,763
  3,948
  4,143
Fixed operating expenses, $m
  1,109
  1,133
  1,158
  1,184
  1,210
  1,236
  1,264
  1,291
  1,320
  1,349
  1,378
  1,409
  1,440
  1,471
  1,504
  1,537
  1,571
  1,605
  1,641
  1,677
  1,714
  1,751
  1,790
  1,829
  1,869
  1,911
  1,953
  1,996
  2,039
  2,084
Total operating expenses, $m
  2,556
  2,621
  2,689
  2,762
  2,838
  2,917
  3,002
  3,090
  3,183
  3,280
  3,091
  3,199
  3,311
  3,427
  3,550
  3,678
  3,813
  3,952
  4,100
  4,253
  4,413
  4,580
  4,756
  4,939
  5,130
  5,331
  5,541
  5,759
  5,987
  6,227
Operating income, $m
  278
  312
  350
  392
  439
  490
  545
  605
  670
  740
  1,106
  1,186
  1,272
  1,365
  1,463
  1,568
  1,680
  1,798
  1,924
  2,058
  2,201
  2,351
  2,511
  2,680
  2,859
  3,049
  3,249
  3,461
  3,685
  3,922
EBITDA, $m
  896
  941
  992
  1,047
  1,107
  1,173
  1,245
  1,322
  1,405
  1,495
  1,590
  1,693
  1,802
  1,918
  2,042
  2,174
  2,314
  2,463
  2,620
  2,787
  2,964
  3,152
  3,350
  3,560
  3,782
  4,017
  4,265
  4,526
  4,803
  5,094
Interest expense (income), $m
  81
  125
  130
  136
  143
  150
  158
  166
  174
  184
  194
  204
  215
  227
  239
  252
  266
  280
  296
  312
  329
  346
  365
  385
  406
  428
  451
  475
  501
  527
  556
Earnings before tax, $m
  154
  182
  214
  249
  289
  332
  379
  431
  486
  546
  902
  971
  1,046
  1,126
  1,211
  1,302
  1,399
  1,503
  1,613
  1,730
  1,854
  1,986
  2,126
  2,274
  2,432
  2,598
  2,774
  2,961
  3,158
  3,367
Tax expense, $m
  41
  49
  58
  67
  78
  90
  102
  116
  131
  148
  243
  262
  282
  304
  327
  352
  378
  406
  435
  467
  501
  536
  574
  614
  657
  701
  749
  799
  853
  909
Net income, $m
  112
  133
  156
  182
  211
  242
  277
  314
  355
  399
  658
  709
  763
  822
  884
  951
  1,022
  1,097
  1,177
  1,263
  1,354
  1,450
  1,552
  1,660
  1,775
  1,897
  2,025
  2,161
  2,305
  2,458

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  4,677
  4,840
  5,015
  5,204
  5,406
  5,622
  5,852
  6,097
  6,357
  6,633
  6,926
  7,235
  7,562
  7,908
  8,272
  8,657
  9,063
  9,490
  9,940
  10,414
  10,914
  11,439
  11,992
  12,573
  13,185
  13,828
  14,504
  15,215
  15,962
  16,748
Adjusted assets (=assets-cash), $m
  4,677
  4,840
  5,015
  5,204
  5,406
  5,622
  5,852
  6,097
  6,357
  6,633
  6,926
  7,235
  7,562
  7,908
  8,272
  8,657
  9,063
  9,490
  9,940
  10,414
  10,914
  11,439
  11,992
  12,573
  13,185
  13,828
  14,504
  15,215
  15,962
  16,748
Revenue / Adjusted assets
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
Average production assets, $m
  3,274
  3,388
  3,510
  3,642
  3,784
  3,935
  4,096
  4,268
  4,450
  4,643
  4,848
  5,064
  5,293
  5,535
  5,790
  6,059
  6,343
  6,642
  6,957
  7,289
  7,639
  8,006
  8,393
  8,800
  9,229
  9,679
  10,152
  10,650
  11,173
  11,722
Working capital, $m
  119
  123
  128
  132
  138
  143
  149
  155
  162
  169
  176
  184
  192
  201
  211
  220
  231
  242
  253
  265
  278
  291
  305
  320
  336
  352
  369
  387
  406
  426
Total debt, $m
  2,411
  2,525
  2,647
  2,779
  2,920
  3,071
  3,231
  3,402
  3,584
  3,777
  3,981
  4,197
  4,425
  4,666
  4,921
  5,189
  5,472
  5,771
  6,085
  6,416
  6,764
  7,131
  7,517
  7,923
  8,350
  8,799
  9,271
  9,767
  10,288
  10,837
Total liabilities, $m
  3,265
  3,378
  3,501
  3,632
  3,773
  3,924
  4,085
  4,256
  4,438
  4,630
  4,834
  5,050
  5,278
  5,520
  5,774
  6,043
  6,326
  6,624
  6,938
  7,269
  7,618
  7,984
  8,370
  8,776
  9,203
  9,652
  10,124
  10,620
  11,142
  11,690
Total equity, $m
  1,413
  1,462
  1,515
  1,572
  1,633
  1,698
  1,767
  1,841
  1,920
  2,003
  2,092
  2,185
  2,284
  2,388
  2,498
  2,614
  2,737
  2,866
  3,002
  3,145
  3,296
  3,455
  3,622
  3,797
  3,982
  4,176
  4,380
  4,595
  4,821
  5,058
Total liabilities and equity, $m
  4,678
  4,840
  5,016
  5,204
  5,406
  5,622
  5,852
  6,097
  6,358
  6,633
  6,926
  7,235
  7,562
  7,908
  8,272
  8,657
  9,063
  9,490
  9,940
  10,414
  10,914
  11,439
  11,992
  12,573
  13,185
  13,828
  14,504
  15,215
  15,963
  16,748
Debt-to-equity ratio
  1.710
  1.730
  1.750
  1.770
  1.790
  1.810
  1.830
  1.850
  1.870
  1.890
  1.900
  1.920
  1.940
  1.950
  1.970
  1.980
  2.000
  2.010
  2.030
  2.040
  2.050
  2.060
  2.080
  2.090
  2.100
  2.110
  2.120
  2.130
  2.130
  2.140
Adjusted equity ratio
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302
  0.302

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  112
  133
  156
  182
  211
  242
  277
  314
  355
  399
  658
  709
  763
  822
  884
  951
  1,022
  1,097
  1,177
  1,263
  1,354
  1,450
  1,552
  1,660
  1,775
  1,897
  2,025
  2,161
  2,305
  2,458
Depreciation, amort., depletion, $m
  618
  629
  641
  655
  669
  684
  700
  717
  735
  755
  485
  506
  529
  553
  579
  606
  634
  664
  696
  729
  764
  801
  839
  880
  923
  968
  1,015
  1,065
  1,117
  1,172
Funds from operations, $m
  730
  762
  797
  837
  879
  926
  977
  1,031
  1,090
  1,154
  1,143
  1,215
  1,293
  1,375
  1,463
  1,557
  1,656
  1,761
  1,873
  1,992
  2,117
  2,250
  2,391
  2,540
  2,698
  2,864
  3,040
  3,226
  3,423
  3,630
Change in working capital, $m
  4
  4
  4
  5
  5
  5
  6
  6
  7
  7
  7
  8
  8
  9
  9
  10
  10
  11
  11
  12
  13
  13
  14
  15
  16
  16
  17
  18
  19
  20
Cash from operations, $m
  726
  758
  793
  832
  874
  921
  971
  1,025
  1,084
  1,147
  1,135
  1,207
  1,284
  1,366
  1,454
  1,547
  1,646
  1,750
  1,862
  1,980
  2,105
  2,237
  2,377
  2,526
  2,682
  2,848
  3,023
  3,208
  3,404
  3,610
Maintenance CAPEX, $m
  -317
  -327
  -339
  -351
  -364
  -378
  -393
  -410
  -427
  -445
  -464
  -485
  -506
  -529
  -553
  -579
  -606
  -634
  -664
  -696
  -729
  -764
  -801
  -839
  -880
  -923
  -968
  -1,015
  -1,065
  -1,117
New CAPEX, $m
  -106
  -114
  -123
  -132
  -141
  -151
  -161
  -172
  -182
  -193
  -205
  -217
  -229
  -242
  -255
  -269
  -284
  -299
  -315
  -332
  -349
  -368
  -387
  -407
  -428
  -450
  -473
  -498
  -523
  -550
Cash from investing activities, $m
  -423
  -441
  -462
  -483
  -505
  -529
  -554
  -582
  -609
  -638
  -669
  -702
  -735
  -771
  -808
  -848
  -890
  -933
  -979
  -1,028
  -1,078
  -1,132
  -1,188
  -1,246
  -1,308
  -1,373
  -1,441
  -1,513
  -1,588
  -1,667
Free cash flow, $m
  304
  317
  332
  349
  369
  391
  416
  444
  475
  508
  467
  506
  549
  595
  645
  698
  756
  817
  882
  952
  1,026
  1,105
  1,190
  1,279
  1,374
  1,475
  1,582
  1,695
  1,816
  1,943
Issuance/(repayment) of debt, $m
  102
  113
  122
  132
  141
  151
  161
  171
  182
  193
  204
  216
  228
  241
  255
  268
  283
  298
  314
  331
  348
  367
  386
  406
  427
  449
  472
  496
  522
  548
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  102
  113
  122
  132
  141
  151
  161
  171
  182
  193
  204
  216
  228
  241
  255
  268
  283
  298
  314
  331
  348
  367
  386
  406
  427
  449
  472
  496
  522
  548
Total cash flow (excl. dividends), $m
  406
  430
  454
  480
  510
  542
  577
  615
  656
  701
  671
  722
  777
  836
  900
  967
  1,039
  1,115
  1,197
  1,283
  1,375
  1,472
  1,576
  1,685
  1,801
  1,924
  2,054
  2,192
  2,337
  2,491
Retained Cash Flow (-), $m
  -47
  -49
  -53
  -57
  -61
  -65
  -70
  -74
  -79
  -83
  -88
  -93
  -99
  -104
  -110
  -116
  -122
  -129
  -136
  -143
  -151
  -159
  -167
  -176
  -185
  -194
  -204
  -215
  -226
  -237
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  22
  23
  23
  24
  25
  26
  27
  28
  30
  31
  32
  34
  35
  37
  38
  40
  42
  44
  46
  48
  50
  53
  55
  58
  61
  64
  67
  70
  74
  77
Cash available for distribution, $m
  359
  381
  401
  423
  449
  477
  507
  541
  578
  618
  582
  629
  679
  732
  789
  851
  916
  986
  1,061
  1,140
  1,224
  1,314
  1,409
  1,509
  1,616
  1,730
  1,850
  1,977
  2,112
  2,254
Discount rate, %
  8.70
  9.14
  9.59
  10.07
  10.57
  11.10
  11.66
  12.24
  12.85
  13.50
  14.17
  14.88
  15.62
  16.41
  17.23
  18.09
  18.99
  19.94
  20.94
  21.98
  23.08
  24.24
  25.45
  26.72
  28.06
  29.46
  30.93
  32.48
  34.11
  35.81
PV of cash for distribution, $m
  331
  320
  305
  288
  271
  253
  234
  215
  195
  174
  136
  119
  103
  87
  73
  60
  48
  37
  29
  21
  16
  11
  8
  5
  3
  2
  1
  1
  0
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Hill-Rom Holdings, Inc. is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company's products and services include Patient Support Systems, Front Line Care and Surgical Solutions. The Company sells and rents its specialty frames and surfaces, and mobility solutions, as well as its clinical workflow solutions, in the United States and Canada through its North America Patient Support Systems segment, and in regions outside of the United States and Canada through its International Patient Support Systems segment. Its Front Line Care segment globally sells and rents respiratory care products, and sells medical diagnostic equipment and a diversified portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases. Under its Surgical Solutions segment, the Company sells its surgical products globally.

FINANCIAL RATIOS  of  Hill-Rom Holdings (HRC)

Valuation Ratios
P/E Ratio 46.5
Price to Sales 2.3
Price to Book 4.6
Price to Tangible Book
Price to Cash Flow 20
Price to Free Cash Flow 29.3
Growth Rates
Sales Growth Rate 3.4%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 18.1%
Cap. Spend. - 3 Yr. Gr. Rate 9.2%
Financial Strength
Quick Ratio 1
Current Ratio 0.1
LT Debt to Equity 156.1%
Total Debt to Equity 170%
Interest Coverage 3
Management Effectiveness
Return On Assets 4.4%
Ret/ On Assets - 3 Yr. Avg. 3.5%
Return On Total Capital 3.8%
Ret/ On T. Cap. - 3 Yr. Avg. 3.2%
Return On Equity 10.4%
Return On Equity - 3 Yr. Avg. 8.6%
Asset Turnover 0.6
Profitability Ratios
Gross Margin 48.1%
Gross Margin - 3 Yr. Avg. 46.6%
EBITDA Margin 17.3%
EBITDA Margin - 3 Yr. Avg. 14.3%
Operating Margin 10%
Oper. Margin - 3 Yr. Avg. 7.5%
Pre-Tax Margin 6.7%
Pre-Tax Margin - 3 Yr. Avg. 5%
Net Profit Margin 4.9%
Net Profit Margin - 3 Yr. Avg. 4%
Effective Tax Rate 27.9%
Eff/ Tax Rate - 3 Yr. Avg. 22.1%
Payout Ratio 35.1%

HRC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the HRC stock intrinsic value calculation we used $2744 million for the last fiscal year's total revenue generated by Hill-Rom Holdings. The default revenue input number comes from 2017 income statement of Hill-Rom Holdings. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our HRC stock valuation model: a) initial revenue growth rate of 3.3% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.7%, whose default value for HRC is calculated based on our internal credit rating of Hill-Rom Holdings, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Hill-Rom Holdings.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of HRC stock the variable cost ratio is equal to 51.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $1085 million in the base year in the intrinsic value calculation for HRC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Hill-Rom Holdings.

Corporate tax rate of 27% is the nominal tax rate for Hill-Rom Holdings. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the HRC stock is equal to 0.8%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for HRC are equal to 115.5%.

Life of production assets of 10 years is the average useful life of capital assets used in Hill-Rom Holdings operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for HRC is equal to 4.2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $1366 million for Hill-Rom Holdings - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 66 million for Hill-Rom Holdings is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Hill-Rom Holdings at the current share price and the inputted number of shares is $6.3 billion.

RELATED COMPANIES Price Int.Val. Rating
SYK Stryker 166.21 73.42  str.sell
ELMD Electromed 5.14 3.69  sell
HYH Halyard Health 57.25 1.60  str.sell

COMPANY NEWS

▶ HRC World PLC: NOTICE OF ANNUAL GENERAL MEETING   [Jul-30-18 12:47PM  GlobeNewswire]
▶ HRC World PLC: CHANGE IN OPERATING STRUCTURE   [07:19AM  GlobeNewswire]
▶ Is Hill-Rom (HRC) Stock Undervalued Right Now?   [Jul-25-18 11:51AM  Zacks]
▶ HRC World PLC: FINANCIAL RESULTS TO 31 MARCH 2018   [Jul-23-18 05:09AM  GlobeNewswire]
▶ Hill-Rom Declares Fiscal 2018 Fourth Quarter Dividend   [Jul-18-18 04:05PM  PR Newswire]
▶ Should You Buy Hill-Rom Holdings Inc (NYSE:HRC)?   [Jun-22-18 09:05AM  Simply Wall St.]
▶ Who Really Owns Grupa HRC Spolka Akcyjna (WSE:HRC)?   [May-15-18 02:39AM  Simply Wall St.]
▶ Hill-Rom Declares Fiscal 2018 Third Quarter Dividend   [May-10-18 06:55AM  PR Newswire]
▶ Hill-Rom: Fiscal 2Q Earnings Snapshot   [07:07AM  Associated Press]
▶ Earnings Outlook For Hill-Rom Holdings   [Apr-26-18 02:28PM  Benzinga]
▶ Calculating The Fair Value Of Hill-Rom Holdings Inc (NYSE:HRC)   [Mar-18-18 10:30AM  Simply Wall St.]
▶ HRC WORLD PLC: LAUNCHING OF HRC MUSIC   [04:01AM  GlobeNewswire]
▶ Hill-Rom Raises Quarterly Dividend   [Mar-07-18 06:55AM  PR Newswire]
▶ 5 Best PEG Stocks Value Investors Love   [Feb-09-18 09:51AM  Zacks]
▶ Hill-Rom beats 1Q profit forecasts   [Jan-26-18 07:13AM  Associated Press]
▶ Hill-Rom Declares Fiscal 2018 First Quarter Dividend   [Nov-08-17 06:59AM  PR Newswire]
▶ Welch Allyn Introduces Connex® Cardio ECG   [Nov-07-17 06:59AM  PR Newswire]
▶ Hill-Rom tops Street 4Q forecasts   [Nov-03-17 07:30AM  Associated Press]
▶ Earnings Season Preview: Hill-Rom Near Buy Zone With Quarterly Report Due   [Oct-30-17 03:00AM  Investor's Business Daily]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.